Medline's Stockholders Price 60 Million Shares at $35.50 Each

MT Newswires Live11-18 17:00

Medline (MDLN) priced its secondary offering of 60 million shares at $35.50 per share, the company said Tuesday.

The company said the selling stockholders, affiliated with Blackstone (BX), Carlyle Group (CG) and Hellman & Friedman, along with GIC and Abu Dhabi Investment Authority, have granted underwriters a 30-day option to purchase up to an additional 9 million shares.

The offering is expected to close Nov. 23, Medline said, adding it is not selling any shares and will not receive proceeds from the offering.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment